70 related articles for article (PubMed ID: 2406878)
1. [Molecular genetics of uterine cervical cancer: application to prognosis].
Riou G
Rev Prat; 1990 Jan; 40(3):239-41. PubMed ID: 2406878
[No Abstract] [Full Text] [Related]
2. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
3. [Cervico-uterine cancer. Influence of cell and viral genes. Implications in the development of vaccines].
Gariglio P
Gac Med Mex; 1998; 134(3):297-307; discussion 309-10. PubMed ID: 9780490
[TBL] [Abstract][Full Text] [Related]
4. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutation of H-ras in uterine cervical cancer.
Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
[TBL] [Abstract][Full Text] [Related]
6. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
Riou GF
Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of prognostic factors in gynecological cancer examined by molecular biological study].
Nagai N
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1004-9. PubMed ID: 8687214
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the ras genes in female genital tract cancer.
Mammas IN; Zafiropoulos A; Spandidos DA
Int J Oncol; 2005 May; 26(5):1241-55. PubMed ID: 15809715
[TBL] [Abstract][Full Text] [Related]
11. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
12. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of gyn malignancies.
Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of HER-2/neu oncogene in cervical cancer.
Ndubisi B; Sanz S; Lu L; Podczaski E; Benrubi G; Masood S
Ann Clin Lab Sci; 1997; 27(6):396-401. PubMed ID: 9433536
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
Willis G; Jennings B; Ball RY; New NE; Gibson I
Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.
Harima Y; Harima K; Sawada S; Tanaka Y; Arita S; Ohnishi T
Clin Cancer Res; 2000 Mar; 6(3):1079-85. PubMed ID: 10741737
[TBL] [Abstract][Full Text] [Related]
18. Should we modify the current FIGO staging system for early-stage cervical cancer?
Petignat P; Loubeyre P
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1015-7. PubMed ID: 18588447
[No Abstract] [Full Text] [Related]
19. [The influense of endogenous and exogenous factors on the development and prognosis of the cancer of the uterine cervix].
Gatenadze TsZ; Sofrani MF; Dzhincharadze MI; Shotadze DT; Chakhoian OP
Georgian Med News; 2009 Apr; (169):10-5. PubMed ID: 19430033
[TBL] [Abstract][Full Text] [Related]
20. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]